Pulmonology

New research finds association common sleep disorder present in 14% of suicidal patients with major depressive disorder studied.

A secondary analysis of a 10,000-patient study has linked lower levels of serum albumin to apnea risk in hospitalized infants.

Standardized mortality ratio increased by nearly a full percentage among patients previously treated with TB.

A new assessment of prevalence studies shows some countries could have an OSA prevalence rate of more than half their entire population.

Study of more than 650 COPD patients found that CRP-guided prescribing resulted in a lower percentage of patients who reported antibiotic use.

A recent study of more than 300,000 found that exposure to outdoor air pollution is linked to decreased lung function and an increased risk of COPD.

A study found that two-thirds receive excess antibiotic treatment and that every excess day increased a patient's risk of adverse events by 5%.

Regardless of which care provider is diagnosing and treating the patient, all must be aware of the treatment access burdens.

The burdensome, inflammatory chronic condition is highlighted by difficult diagnoses and screening options. How is research advancing to improve care?

After showing the ability to regain patients' senses of smell and taste in a pair of phase 3 trials, the biologic becomes the first indicated for CRSwNP.

A new pooled cohort analysis supports the longheld threshold of < .70 FEV1:FVC ratio to indicate patient risks from COPD-related events.

A new retrospective cohort finds that patients with untreated obstructive sleep apnea face a two-fold greater risk of developing T2D.

The FDA had previously only certified Symdeko tablets for treatment of children aged 12 years and older.

The endothelin receptor antagonist has proven benefits and safety for PAH patients burdened with liver or extrahepatic disease risks.

A three-arm clinical trial of the SAMBA program showed that screening for and tailoring to individuals' asthma needs improves their condition management.

New findings better evidence the link between long-term COPD exacerbations and poor patient sleep quality. How well-understood is the association between sleep and pulmonary conditions?

An assessment of the CanCOLD study showed that COPD exacerbations over 18 months were greater in patients with worse scores for sleep quality at baseline.

The rare, chronic condition requires investigators to turn to unique registries and other patient populations to access therapy benefits.

Overall rates of pulmonary rehabilitation rose in areas with greater program density, but rates for African Americans remained low despite greater program density.

The signs and symptoms of the rare, chronic condition are not consistently detected in the first line of care.

The real-world analysis of epicutaneous therapy for milk-related EoE progressively exposed pediatric patients to their milk allergen.

A new study from ATS showed an early symptom of Alzheimer disease is more prevalent in older patients with moderate OSA.

Neighborhoods redlined in the 1930s continue to feel the effects of the racially discriminatory practice, including differences in asthma-related emergency visits.

Sleep apnea is associated with pulmonary, cardiovascular, psychiatric, neurologic, and weight-related effects. Primary care physicians need to monitor sleep health more.

Previous analyses into MultiStem Cell Therapy have shown benefits and safety in stroke patients. What will it take for the therapy to reach a phase 3 trial for ARDS?